You had searched for:
There were no results matching the query.
You can also browse the topics below to find what you are looking for.
Clinical trials for AJOVY
AJOVY was evaluated in HALO, two phase 3, 12-week, randomized, double-blind, placebo-controlled, parallel-group trials.1,2
AJOVY was also evaluated in FOCUS, a phase 3b, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, evaluating efficacy and safety of quarterly and monthly treatment with AJOVY, compared to placebo in patients with chronic or episodic migraine who had experienced inadequate response to 2–4 classes of prior preventive treatments.3SEE EFFICACY RESULTS IN CLINICAL TRIALS FOR AJOVY